From the age of 40, plasma levels of NAD+ (nicotinamide adenine dinucleotide) decline progressively, reaching a loss of up to 50% by the age of 60. NAD+ is an essential cofactor for more than 500 cellular reactions, including mitochondrial ATP production and the activity of sirtuins, regulatory proteins associated with longevity.
This decline is not theoretical: it translates into less sustained energy, slower recovery after exertion, and greater vulnerability to oxidative stress and the accumulation of DNA damage. Without sufficient NAD+, sirtuins are silenced — and with them, an important layer of the cellular maintenance system is lost.
The Pleniage approach to caring for cellular vitality combines bioavailable NAD+ precursors (Nicotinamide Riboside or NR) with complementary cofactors, in clinically studied doses. It is not a cure-all: it is metabolic support backed by science.